Anika Therapeutics, Inc.
—- Market cap
- $276.76M
- Debt
- —
- Cash
- −$57.48M
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ANIK · price snapshotP/S 2.45x
$20.68Snapshot Sep 10, 2026, 11:15 AM ET
Implied fair value · at NFE's multiple
$0.4697.8% below market
8.43 ANIK revenue / share×0.05x NFE P/S=$0.46
Market $20.68Implied $0.46
NFE · price snapshotP/S 0.05x
$0.29Snapshot Sep 10, 2026, 11:15 AM ET
Implied fair value · at ANIK's multiple
$12.924,360.4% above market
5.27 NFE revenue / share×2.45x ANIK P/S=$12.92
Market $0.29Implied $12.92